Acetylcysteine for prevention of contrast nephropathy: meta-analysis.


BACKGROUND Contrast nephropathy is associated with increased in-hospital morbidity and mortality and leads to extension of hospital stay in patients with chronic renal insufficiency. Acetylcysteine seems to be a safe and inexpensive way to reduce contrast nephropathy. We aimed to assess the efficacy of acetylcysteine to prevent contrast nephropathy after… (More)


Cite this paper

@article{Birck2003AcetylcysteineFP, title={Acetylcysteine for prevention of contrast nephropathy: meta-analysis.}, author={Rainer Birck and Stefan Krzossok and Florian Markowetz and Peter Schnuelle and Fokko Johannes van der Woude and Claude Braun}, journal={Lancet}, year={2003}, volume={362 9384}, pages={598-603} }